Cargando…

p53 Modulation as a Therapeutic Strategy in Gastrointestinal Stromal Tumors

The KIT-inhibitor imatinib mesylate (IM) has greatly improved the treatment of metastatic gastrointestinal stromal tumors (GIST). IM exhibits strong antiproliferative effects but fails to induce sufficient levels of apoptosis resulting in low pathologic complete remission rates and a high rate of se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henze, Joern, Mühlenberg, Thomas, Simon, Susanne, Grabellus, Florian, Rubin, Brian, Taeger, Georg, Schuler, Martin, Treckmann, Juergen, Debiec-Rychter, Maria, Taguchi, Takahiro, Fletcher, Jonathan A., Bauer, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360609/ https://www.ncbi.nlm.nih.gov/pubmed/22662219 http://dx.doi.org/10.1371/journal.pone.0037776

Ejemplares similares

Inhibition of KIT-Glycosylation by 2-Deoxyglucose Abrogates KIT-Signaling and Combination with ABT-263 Synergistically Induces Apoptosis in Gastrointestinal Stromal Tumor
por: Mühlenberg, Thomas, et al.
Publicado: (2015)

Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)
por: Heinrich, Michael C., et al.
Publicado: (2019)

Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors
por: Bauer, S, et al.
Publicado: (2014)

Clinical implications of mutational analysis in gastrointestinal stromal tumours
por: Hoeben, A, et al.
Publicado: (2008)

Trabectedin in metastatic soft tissue sarcomas: Role of pretreatment and age
por: HOICZYK, MATHIAS, et al.
Publicado: (2013)

Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinib
por: Falkenhorst, Johanna, et al.
Publicado: (2016)

The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas
por: Schwindenhammer, Benjamin, et al.
Publicado: (2013)

Drug dosage in isolated limb perfusion: evaluation of a limb volume model for extremity volume calculation
por: Podleska, Lars Erik, et al.
Publicado: (2014)

Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models()()
por: Van Looy, Thomas, et al.
Publicado: (2015)

Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors
por: Wang, Yannick, et al.
Publicado: (2020)

Post-Transcriptional Dysregulation by miRNAs Is Implicated in the Pathogenesis of Gastrointestinal Stromal Tumor [GIST]
por: Kelly, Lorna, et al.
Publicado: (2013)

What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?
por: Rutkowski, Piotr, et al.
Publicado: (2013)

Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors
por: Van Looy, Thomas, et al.
Publicado: (2014)

Gastrointestinal stromal tumors
por: Beham, Alexander W., et al.
Publicado: (2011)

Molecular Comparison of Imatinib-Naïve and Resistant Gastrointestinal Stromal Tumors: Differentially Expressed microRNAs and mRNAs
por: Amirnasr, Azadeh, et al.
Publicado: (2019)

Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumors
por: Edris, Badreddin, et al.
Publicado: (2013)

MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours
por: Gits, C M M, et al.
Publicado: (2013)

Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells
por: Rausch, Jessica L., et al.
Publicado: (2020)

Gastrointestinal Stromal Tumours: An Update
por: Somerhausen, Nicolas De Saint Aubain, et al.
Publicado: (1998)

Plasma Sequencing for Patients with GIST—Limitations and Opportunities in an Academic Setting
por: Falkenhorst, Johanna, et al.
Publicado: (2022)

p53 as a biomarker and potential target in gastrointestinal stromal tumors
por: Wu, Chiao-En, et al.
Publicado: (2022)

TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculature
por: Podleska, L E, et al.
Publicado: (2015)

TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculature
por: Podleska, L E, et al.
Publicado: (2015)

Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumor
por: Serrano, César, et al.
Publicado: (2019)

Gastrointestinal Stromal Tumors: Molecular Mechanisms and Targeted Therapies
por: Downs-Kelly, Erinn, et al.
Publicado: (2011)

High-grade endometrial stromal sarcoma presenting in a 28-year-old woman during pregnancy: a case report
por: Amant, Frédéric, et al.
Publicado: (2010)

A rare case of atypical/anaplastic meningioma with MDM2 amplification
por: Wylleman, Robbert, et al.
Publicado: (2018)

Epidemiology, survival, and costs of localized gastrointestinal stromal tumors
por: Rubin, Jaime L, et al.
Publicado: (2011)

Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions
por: Bauer, Sebastian, et al.
Publicado: (2015)

A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors
por: Isosaka, Mai, et al.
Publicado: (2015)

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
por: Serrano, César, et al.
Publicado: (2019)

Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis
por: Ichikawa, Hiroshi, et al.
Publicado: (2015)

Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
por: Serrano, César, et al.
Publicado: (2019)

Gastrointestinal stromal tumor
por: Stamatakos, Michael, et al.
Publicado: (2009)

Cellular Angiofibroma of the Prostate: A Rare Tumor in an Unusual Location
por: Wyn, Inez, et al.
Publicado: (2014)

Gastrointestinal Stromal Tumor: Cause of Gastrointestinal Bleeding
por: Vilallonga, Ramon, et al.
Publicado: (2010)

Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor
por: Bauer, Sebastian, et al.
Publicado: (2021)

Neurotensin Receptor 1 Is Expressed in Gastrointestinal Stromal Tumors but Not in Interstitial Cells of Cajal
por: Gromova, Petra, et al.
Publicado: (2011)

Laparoscopic resection of large gastric gastrointestinal stromal tumours
por: Smolarek, Sebastian, et al.
Publicado: (2015)

All-trans retinoic acid inhibits KIT activity and induces apoptosis in gastrointestinal stromal tumor GIST-T1 cell line by affecting on the expression of survivin and Bax protein
por: Chi, Hoang Thanh, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_a4192fsb4vtk68tpa46s4q07c0